These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 22650234)

  • 1. Network pharmacology for cancer drug discovery: are we there yet?
    Azmi AS
    Future Med Chem; 2012 May; 4(8):939-41. PubMed ID: 22650234
    [No Abstract]   [Full Text] [Related]  

  • 2. Precision cancer medicine: where to target?
    Yu Q; Ding J
    Acta Pharmacol Sin; 2015 Oct; 36(10):1161-2. PubMed ID: 26388154
    [No Abstract]   [Full Text] [Related]  

  • 3. Multi-targeted hybrids based on HDAC inhibitors for anti-cancer drug discovery.
    Seo SY
    Arch Pharm Res; 2012 Feb; 35(2):197-200. PubMed ID: 22370774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current trends in epigenetic drug discovery.
    Stolfa DA; Einsle O; Sippl W; Jung M
    Future Med Chem; 2012 Oct; 4(16):2029-37. PubMed ID: 23157236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The emerging role of CXC chemokines and their receptors in cancer.
    Vinader V; Afarinkia K
    Future Med Chem; 2012 May; 4(7):853-67. PubMed ID: 22571611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular Pathway Analysis of Mutation Data for Biomarkers Discovery and Scoring of Target Cancer Drugs.
    Zolotovskaia M; Sorokin M; Garazha A; Borisov N; Buzdin A
    Methods Mol Biol; 2020; 2063():207-234. PubMed ID: 31667773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug discovery strategies in the field of tumor energy metabolism: Limitations by metabolic flexibility and metabolic resistance to chemotherapy.
    Amoedo ND; Obre E; Rossignol R
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):674-685. PubMed ID: 28213330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

  • 9. Oncobox Method for Scoring Efficiencies of Anticancer Drugs Based on Gene Expression Data.
    Tkachev V; Sorokin M; Garazha A; Borisov N; Buzdin A
    Methods Mol Biol; 2020; 2063():235-255. PubMed ID: 31667774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence networks based on coexpression improve drug target discovery for the development of novel cancer therapeutics.
    Penrod NM; Moore JH
    BMC Syst Biol; 2014 Feb; 8():12. PubMed ID: 24495353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Network based approach to drug discovery: a mini review.
    Li P; Fu Y; Wang Y
    Mini Rev Med Chem; 2015; 15(8):687-95. PubMed ID: 25694073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Network pharmacology and drug discovery].
    Wang J; Li XJ
    Sheng Li Ke Xue Jin Zhan; 2011 Aug; 42(4):241-5. PubMed ID: 22066413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug target identification in sphingolipid metabolism by computational systems biology tools: metabolic control analysis and metabolic pathway analysis.
    Ozbayraktar FB; Ulgen KO
    J Biomed Inform; 2010 Aug; 43(4):537-49. PubMed ID: 20348024
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mathematical modeling in cancer drug discovery.
    Wang Z; Deisboeck TS
    Drug Discov Today; 2014 Feb; 19(2):145-50. PubMed ID: 23831857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia-directed drug strategies to target the tumor microenvironment.
    Hay MP; Hicks KO; Wang J
    Adv Exp Med Biol; 2014; 772():111-45. PubMed ID: 24272357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer stem cells as a target population for drug discovery.
    Bouvard C; Barefield C; Zhu S
    Future Med Chem; 2014 Sep; 6(14):1567-85. PubMed ID: 25367391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent progress in the discovery of small-molecule inhibitors of the HMT EZH2 for the treatment of cancer.
    Verma SK; Knight SD
    Future Med Chem; 2013 Sep; 5(14):1661-70. PubMed ID: 24047271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rectifying cancer drug discovery through network pharmacology.
    Azmi AS; Mohammad RM
    Future Med Chem; 2014 Apr; 6(5):529-39. PubMed ID: 24649956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterizing and optimizing human anticancer drug targets based on topological properties in the context of biological pathways.
    Zhang J; Wang Y; Shang D; Yu F; Liu W; Zhang Y; Feng C; Wang Q; Xu Y; Liu Y; Bai X; Li X; Li C
    J Biomed Inform; 2015 Apr; 54():132-40. PubMed ID: 25724580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NCI-60 Cell Line Screening: A Radical Departure in its Time.
    Chabner BA
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26755050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.